Recent studies have suggested that Plesiomonas shigelloides is a cause of diarrhea. The present study addresses the clinical features, epidemiology, and response to antimicrobial therapy of P. shigelloides diarrhea. Thirty cases of P. shigelloides infection were defined by isolation of the organism from stool specimens, and 30 age-matched control patients were identified by detection of other enteric pathogens. Clinical and epidemiological information was obtained by interviewing the referring physicians and the patients. Of the P. shigelloides-infected patients, 71% had a history of recent tropical travel, but 29% acquired their infections locally in association with the consumption of seafood or untreated water or both. Seventy-eight percent of the P. shigelloides-infected patients had findings suggestive of colitis, and P. shigelloides-infected patients had a history of tropical travel, acute illness, abdominal pain, and prolonged symptoms significantly more often than did the control patients. Antimicrobial therapy significantly reduced the duration of illness in patients with Plesiomonas diarrhea. These results suggest that P. shigelloides is a significant cause of both locally acquired and traveler's diarrhea that may respond to antimicrobial therapy.
Plesiomonas shigelloides is an oxidase-positive, fermentative, gram-negative rod belonging to the family Vibrionaceae. Several reports have implicated the organism as a cause of sporadic and epidemic diarrheal disease (6, 14) , and a recent case-controlled study involving 31 P. shigelloides isolates from across the United States provided additional support for the role of the organism as a cause of diarrhea (7) . Other studies have indicated that P. shigelloides is isolated from <0.1% of asymptomatic individuals (1, 10 (16) , which has been suggested as a selective-differential medium for the detection of P. shigelloides. Most specimens were examined for intestinal parasites by using permanent iron hematoxylin stain and Formalin-ethyl acetate concentration.
The enteric plating media and campylobacter-selective agar were screened for potential pathogens in accordance with standard procedures (8) . Blood agar cultures were screened by flooding the plates with oxidase reagent and selecting oxidase-positive colonies for identification. Whitish or pinkish colonies on inositol-brilliant green-bile salts agar were subcultured to blood agar and tested for oxidase. Potential pathogens were identified by classical biochemical testing with serological confirmation of Salmonella and Shigella isolates. The following characteristics were required for identification of isolates as P. shigelloides: positivity for oxidase, indole, myoinositol, arginine, lysine, and ornithine; negativity for hydrogen sulfide, gas, urease, arabinose, mannitol, sucrose, and DNase; and a negative VogesProskauer test (15) . P. shigelloides isolates were tested for antimicrobial susceptibility by using a standard disk-diffusion method (2) .
Statistical analysis. The findings for P. shigelloides-in- shigelloides-infected patients (95%) for whom information was available consumed seafood or untreated water within 5 days of the onset of symptoms. Infections with P. shigelloides in travelers were seen year-round, but locally acquired infections were detected only in July, August, and September. Four P. shigelloides-infected patients had consumed codeine before their illness, but they were significantly less likely to have ingested this or other medication than were controls (4 of 22 patients versus 13 of 30 controls; P = 0.05). There were no significant differences between control patients and P. shigelloides-infected patients with respect to age, sex, or presence of underlying disease.
All patients yielding P. shigelloides were symptomatic and had diarrhea (Table 1) . Seventy-eight percent of these patients sought medical attention within 2 weeks of the onset of illness, whereas only 39% of the control patients had such an acute illness. Plesiomonas diarrhea appears to involve predominantly the large bowel (colitis), and patients often had small-volume stools associated with lower abdominal pain, urgency, or tenesmus. Symptoms of colitis tended to be more common in P. shigelloides-infected patients (78%) than in control patients (53.6%), but the difference was not statistically significant (P = 0.06). Consistent with their symptoms of colitis, 27% of the P. shigelloides-infected patients experienced bloody stools, 30% had fever, 64% had fecal leukocytes, and 78% had often-severe left-lowerquadrant or hypogastric pain, and they were significantly more likely to experience abdominal discomfort than were the control patients. Forty percent of P. shigelloides-infected patients had nausea or vomiting, often early in the course of illness, and 3 of 27 (11%) experienced transient arthralgias.
Two patients with Plesiomonas infection underwent colorectal endoscopy and biopsy, and the results were abnormal for one of them. This biopsy was done during week 5 of illness, and the findings were interpreted as chronic nonspecific colitis. The symptoms of this patient subsequently resolved during week 7 of illness. Overall, the symptoms of Plesiomonas infection were of longer duration than those of the control patient infections.
Of the 30 Plesiomonas strains isolated from the study patients, 19 underwent antimicrobial susceptibility testing. Of The results presented above are from patients infected with P. shigelloides with or without other enteric pathogens. To more closely define the role of P. shigelloides in diarrhea, the results were reanalyzed for the 19 patients infected with P. shigelloides alone. No differences were found in the clinical features, epidemiology, or response to therapy when the results for these patients were compared with those for the 30 patients analyzed above.
DISCUSSION
These findings suggest that P. shigelloides is a cause of both locally acquired and traveler's diarrhea and that the organism occurs more commonly than is currently recognized. Thirty-four patients with Plesioinonas diarrhea were found, despite the fact that no media were used to enhance recovery of the organism during most of the study period. Twenty of the P. shigelloides-infected patients had a history of recent tropical travel, but eight patients had no history of recent travel outside British Columbia. Experience with other enteric pathogens suggests that additional cases of Plesiomnonas infection will be recognized when a more effective medium for isolating the organism becomes available.
Little is known of the epidemiology of P. shigelloides diarrhea. Waterborne (1, 14) and oyster-related (13) outbreaks of Plesiomonas diarrhea have been reported, and a recent case-controlled study suggested that consumption of raw oysters and travel outside the United States are risk factors for acquiring the infection (7) . In the present study, the organism was found to affect all age groups and both males and females, and Plesiomonas diarrhea was significantly associated with tropical travel and with consumption of seafood or untreated water.
The clinical features of Plesiomonas infection in previous uncontrolled studies have suggested that the organism causes either secretory or invasive diarrhea. In a recent review, it was concluded that Plesiomonas diarrhea is most often secretory in nature and that invasive diarrhea occurs less commonly (3). Our findings and the results of another recent study (7) indicate that most patients with Plesiomonas infection have an acute illness, with abdominal pain and colitis. These findings suggest that invasive rather than secretory diarrhea is most commonly associated with Plesiomonas infection.
The results of several recent studies support the role of P. shigelloides as an enteric pathogen, and the results presented here demonstrate that this organism produces symptoms of infection with a frequency comparable to or exceeding that associated with other recognized enteric pathogens. Although these findings indicate that P. shigelloides is an enteric pathogen, an understanding of the mechanism of pathogenesis of the organism has been elusive, and previous in vitro studies of P. shigelloides pathogenesis have been inconclusive (3) (4) (5) 7) . Studies of the mechanisms of pathogenesis in the strains isolated in this study are under way.
Little information on the natural history of P. shigelloides diarrhea is available from previous studies, but the results of the present study suggest that the organism often causes prolonged illness. We found that 76% of the P. shigelloidesinfected patients had symptoms lasting more than 2 weeks, and 32% had symptoms lasting more than 4 weeks. This duration of symptoms was significantly longer than that seen in patients infected with other organisms (P < 0.05) and is consistent with other reports of prolonged illness associated with P. shigelloides infection (3, 7, 12) .
The results of several previous uncontrolled studies have suggested that P. shigelloides diarrhea responds to antimicrobial therapy (9, 11) . Our findings suggest that P. shigelloides-infected patients treated with antimicrobial agents to which the organism was susceptible had a significantly briefer illness than untreated patients. Although this study was not randomized and the number of patients studied was small, our results suggest that antimicrobial therapy is beneficial in P. shigelloides diarrhea. Additional controlled studies are needed in this area.
In summary, the present findings support the role of P. shigelloides as a gastrointestinal pathogen and indicate that the organism may be a more common cause of diarrhea than is currently recognized. In British Columbia, Plesioinonas diarrhea may be locally acquired or associated with tropical travel and is often related to consumption of seafood or untreated water. Study patients with Plesiornonas diarrhea had a more acute illness, more often had abdominal pain, and had a longer duration of illness than did control patients, who were infected with other enteric pathogens. Our findings suggest that the organism produces a clinical illness that resembles invasive diarrhea and that may respond to antimicrobial therapy. P. shigelloides may be an important new enteric pathogen.
